✦ LIBER ✦

Effect of a specific cox-2 inhibitor on gastroduodenal lesions in patients with familial adenomatous polyposis

✍ Scribed by M.G. De Palo; M. Mutignani; N. Maggiano; A. Pastorelli; V. Rovella; E. Sanz Torre; S. Dalvai; S. Rinelli; F. Vecchio; G. Costamagna; M. Anti

Book ID: 119630627
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 162 KB
Volume: 33
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(01)80534-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of indomethacin suppositories on

Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis

✍ Chiharu Hirota; Mitsuo Iida; Kunihiko Aoyagi; Takayuki Matsumoto; Shuji Tada; Ta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

## BACKGROUND. Oral sulindac is known to reduce polyps in patients with familial adenomatous polyposis (FAP). The authors speculated that rectal administration of indomethacin would he effective therapy for adenomas in the rectal remnant of FAP. METHODS. Eight patients with FAP who had been treate

Retinal Pigment Epithelium Lesions as a

Retinal Pigment Epithelium Lesions as a Biomarker of Disease in Patients with Familial Adenomatous Polyposis

✍ Romania, Anthony; Zakov, Z. Nicholas; Church, James M.; Jagelman, David G. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 575 KB

A randomized trial comparing ursodeoxych

A randomized trial comparing ursodeoxycholic acid and rofecoxib, a selective Cox-2 inhibitor, in the treatment of advanced duodenal adenomas in patients with familial adenomatous polyposis

✍ Maclean, Anthony R.; McLeod, Robin S.; Berk, Terri; Gallinger, Steven 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Impact ofPhospholipase A2 Group IIaGene

Impact ofPhospholipase A2 Group IIaGene Polymorphism on Phenotypic Features of Patients with Familial Adenomatous Polyposis

✍ Ritsuko Yanaru-Fujisawa; Takayuki Matsumoto; Yoji Kukita; Shotaro Nakamura; Taka 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 223 KB

M1942 A Double Bind Placebo Controlled A

M1942 A Double Bind Placebo Controlled Assessment of Mucosal Changes of the Duodenum in Patients with Familial Adenomatous Polyposis (FAP) After Treatment with a COX-2 Inhibitor (Rofecoxib)

✍ Aabakken, Lars; Fausa, Olav; Pascual, Ana Lobato; Schjolberg, Aasa; Andresen, Pe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Randomized controlled trial of the effec

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis

✍ K. P. Nugent; K. C. R. Farmer; A. D. Spigelman; C. B. Williams; Mr R. K. S. Phil 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 2 views